Biopure Case.

Q.1 What are the reasons for and against immediately launching Oxyglobin? For <Tab/>Will build a brand for Bio pure which will be helpful when launching Hemopure. <Tab/>They can learn from their mistakes during the launch of Oxyglobin <Tab/>Will be good for Hemopure later on because people would already be comfortable with the idea of using a blood …

…distribution channels and goodwill of Biopure corporation. As for the costs as already mentioned to penetrate the human blood market the pricing should be about $ 400 rather than $ 700 so as to achieve market penetration. First of all consumers would be ready to pay more for Hemopure as human life is perceived to be more valuable than animal life. Also if required the company can stress effectively on the process difference between making of Hemopure and Oxyglobin.